Judges Scientific (GB:JDG) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Judges Scientific has faced challenging trading conditions in the first half of 2024, with improvements anticipated in the second half. Despite a 4.2% increase in organic order intake year-to-date, the company now expects adjusted earnings per share to be between 270p and 300p, lower than previously forecasted. The board remains confident in the long-term growth prospects of the business.
For further insights into GB:JDG stock, check out TipRanks’ Stock Analysis page.